Therapeutic expertise

Metabolic Disease Clinical Trial Sites

WCR supports evaluation of metabolic-disease programs through coordinated investigator review, private-practice patient access, bilingual recruitment, and clinical infrastructure.

Program fit

Connected expertise across complex chronic conditions

Metabolic protocols often intersect with obesity, diabetes, cardiovascular risk, and digestive health. WCR reviews the full target population and procedure set before recommending Miami Lakes, Puerto Rico, or both.

  • Metabolic syndrome
  • Dyslipidemia
  • Insulin resistance
  • Cardiometabolic risk
  • Fatty liver-related conditions
  • Obesity-related metabolic disease

Operational support

  • Multi-specialty investigator review
  • Clinical sample collection and processing
  • Temperature-controlled sample storage
  • Local laboratory retesting access
  • Bilingual participant communication

From our case studies

Obesity: readiness translated into recruitment

First screening occurred two days after activation. Across the study, 22 people were screened and 20 were randomized. The case separates the startup milestone from the later recruitment totals.

2days: activation to first screening
22participants screened in total
20participants randomized in total
Read the full study story

For sponsors & CROs

Connect metabolic expertise with realistic recruitment planning

WCR’s metabolic research capabilities connect obesity, diabetes and cardiovascular-risk experience across its Miami Lakes and Puerto Rico network. Existing expertise includes metabolic syndrome, dyslipidemia, insulin resistance and fatty liver-related conditions. Feasibility brings the proposed population together with treatment history, laboratory needs, procedures and the visit schedule. The published obesity cases provide study-specific examples of recruitment preparation and coordinated follow-through.

From feasibility to study visits

  1. Use the broader metabolic population to inform study-specific feasibility rather than equating records with eligible participants.

  2. Review the protocol across related diabetes, obesity and cardiovascular requirements.

  3. Coordinate clinical samples, participant appointments and long-term follow-up needs.

Relevant investigator experience

Clinical experience behind the feasibility review

Miami Lakes, Florida

Lucky Flores, MD

Research experience across GI, dermatology, obesity, diabetes, respiratory disease, vaccines and women’s health.

Puerto Rico

Gustavo R. Albizu-Angulo, MD

Research experience in obesity, diabetes, cardiovascular risk, inflammatory bowel disease, vaccines, asthma and migraine.

Puerto Rico

Juan Carlos Rivera Arce, MD

Cardiology and internal-medicine experience spanning cardiovascular disease, arrhythmias and metabolic risk.

Investigator assignment, location suitability and study-specific resources are confirmed during feasibility. Explore both research locations

Related network experience

The work behind the study results

Phase 3

Obesity with diabetes

WCR prepared staffing and patient access together. Early engagement with private-practice patients was matched by additional full-time team members and new hires before the study started.

Review this case study

Phase 3b

Obesity and weight maintenance

Patients from the investigator’s private practice formed the candidate pool. Early prescreening and engagement helped recruitment move forward while WCR coordinated research visits, outside assessments, and counseling.

Review this case study

For participants

Learn about metabolic research opportunities

Study availability and eligibility vary. The research team explains the protocol, visits, procedures, risks, and possible benefits before enrollment.

View Enrolling Trials

Related expertise

Connected therapeutic areas

Evaluate a metabolic-disease protocol